Skip to main content
Erschienen in: European Radiology 10/2010

01.10.2010 | Breast

Neoadjuvant chemotherapy for breast cancer: correlation between the baseline MR imaging findings and responses to therapy

verfasst von: Takayoshi Uematsu, Masako Kasami, Sachiko Yuen

Erschienen in: European Radiology | Ausgabe 10/2010

Einloggen, um Zugang zu erhalten

Abstract

Objective:

To retrospectively evaluate the magnetic resonance (MR) imaging findings of breast cancer before neoadjuvant chemotherapy (NAC) and to compare findings of chemosensitive breast cancer with those of chemoresistant breast cancer.

Methods:

The MR imaging findings before NAC in 120 women undergoing NAC were reviewed. The MR imaging findings were compared with the pathological findings and responses.

Results:

A complete response (pCR) and marked response were achieved in 12 and 35% of 120 breast cancers in 120 women respectively. Breast cancers with a pCR or marked response were classified as chemosensitive breast cancer. The remaining 64 breast cancers (53%) were classified as chemoresistant breast cancer. Large tumour size, a lesion without mass effect, and very high intratumoural signal intensity on T2-weighted MR images were significantly associated with chemoresistant breast cancer. Lesions with mass effect and washout enhancement pattern were significantly associated with chemosensitive breast cancer. Areas with very high intratumoural signal intensity on T2-weighted images corresponded pathologically to areas of intratumoural necrosis.

Conclusion:

Several MR imaging features of breast cancer before NAC can help predict the efficacy of NAC.
Literatur
1.
Zurück zum Zitat Rosen EL, Blackwell KL, Baker JA et al (2003) Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. AJR Am J Roentgenol 181:1275–1282PubMed Rosen EL, Blackwell KL, Baker JA et al (2003) Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. AJR Am J Roentgenol 181:1275–1282PubMed
2.
Zurück zum Zitat Partridge SC, Gibbs JE, Lu Y, Esserman LJ, Sudilovsky D, Hylton NM (2002) Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR Am J Roentgenol 179:1193–1199PubMed Partridge SC, Gibbs JE, Lu Y, Esserman LJ, Sudilovsky D, Hylton NM (2002) Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR Am J Roentgenol 179:1193–1199PubMed
3.
Zurück zum Zitat Londero V, Bazzocchi M, Frate CD et al (2004) Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy. Eur Radiol 14:1371–1379CrossRefPubMed Londero V, Bazzocchi M, Frate CD et al (2004) Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy. Eur Radiol 14:1371–1379CrossRefPubMed
4.
Zurück zum Zitat Balu-Maestro C, Chapellier C, Bleuse A, Chanalet I, Chauvel C, Largillier R (2002) Imaging in evaluation of response to neoadjuvant breast cancer treatment benefits of MRI. Breast Cancer Res Treat 72:145–152CrossRefPubMed Balu-Maestro C, Chapellier C, Bleuse A, Chanalet I, Chauvel C, Largillier R (2002) Imaging in evaluation of response to neoadjuvant breast cancer treatment benefits of MRI. Breast Cancer Res Treat 72:145–152CrossRefPubMed
5.
Zurück zum Zitat Akazawa K, Tamaki Y, Taguchi T et al (2006) Preoperative evaluation of residual tumor extent by three-dimensional magnetic resonance imaging in breast cancer patients treated with neoadjuvant chemotherapy. Breast J 12:130–137CrossRefPubMed Akazawa K, Tamaki Y, Taguchi T et al (2006) Preoperative evaluation of residual tumor extent by three-dimensional magnetic resonance imaging in breast cancer patients treated with neoadjuvant chemotherapy. Breast J 12:130–137CrossRefPubMed
6.
Zurück zum Zitat Abraham DC, Jones RC, Jones SE et al (1996) Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging. Cancer 78:91–100CrossRefPubMed Abraham DC, Jones RC, Jones SE et al (1996) Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging. Cancer 78:91–100CrossRefPubMed
7.
Zurück zum Zitat Yeh E, Slanetz P, Kopans DB et al (2005) Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. AJR Am J Roentgenol 184:868–877PubMed Yeh E, Slanetz P, Kopans DB et al (2005) Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. AJR Am J Roentgenol 184:868–877PubMed
8.
Zurück zum Zitat Esserman L, Kaplan E, Partridge S et al (2001) MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage 3 breast cancer. Ann Surg Oncol 8:549–559CrossRefPubMed Esserman L, Kaplan E, Partridge S et al (2001) MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage 3 breast cancer. Ann Surg Oncol 8:549–559CrossRefPubMed
9.
Zurück zum Zitat Martincich L, Montemurro F, Cirillo S et al (2003) Role of magnetic resonance imaging in the prediction of tumor response in patients with locally advanced breast cancer receiving neoadjuvant chemo-therapy. Radiol Med 106:51–56PubMed Martincich L, Montemurro F, Cirillo S et al (2003) Role of magnetic resonance imaging in the prediction of tumor response in patients with locally advanced breast cancer receiving neoadjuvant chemo-therapy. Radiol Med 106:51–56PubMed
10.
Zurück zum Zitat Murata Y, Ogawa Y, Yoshida S et al (2004) Utility of initial MRI for predicting extent of residual disease after neoadjuvant chemotherapy: analysis of 70 breast cancer patients. Oncol Rep 12:1257–1262PubMed Murata Y, Ogawa Y, Yoshida S et al (2004) Utility of initial MRI for predicting extent of residual disease after neoadjuvant chemotherapy: analysis of 70 breast cancer patients. Oncol Rep 12:1257–1262PubMed
11.
Zurück zum Zitat Ikeda DM, Hylton NM, Kuhl CK et al (2003) Breast imaging reporting and data system, BI-RADS: MRI, 4th edn. American College of Radiology, Reston, VA Ikeda DM, Hylton NM, Kuhl CK et al (2003) Breast imaging reporting and data system, BI-RADS: MRI, 4th edn. American College of Radiology, Reston, VA
12.
Zurück zum Zitat Egan RL (1982) Multicentric breast carcinomas: clinical-radiographic-pathologic whole organ studies and 10-year survival. Cancer 49:1123–1130CrossRefPubMed Egan RL (1982) Multicentric breast carcinomas: clinical-radiographic-pathologic whole organ studies and 10-year survival. Cancer 49:1123–1130CrossRefPubMed
13.
Zurück zum Zitat Kurosumi M, Akashi-Tanaka S, Akiyama F et al (2008) Histopathological criteria for assessment of therapeutic response in breast cancer (2007 version). Breast Cancer 15:5–7CrossRefPubMed Kurosumi M, Akashi-Tanaka S, Akiyama F et al (2008) Histopathological criteria for assessment of therapeutic response in breast cancer (2007 version). Breast Cancer 15:5–7CrossRefPubMed
14.
Zurück zum Zitat Esserman L, Hylton N, George T, Weidner N (1999) Contrast-enhanced magnetic resonance imaging to assess tumor histopathology and angiogenesis in breast carcinoma. Breast J 5:13–21CrossRefPubMed Esserman L, Hylton N, George T, Weidner N (1999) Contrast-enhanced magnetic resonance imaging to assess tumor histopathology and angiogenesis in breast carcinoma. Breast J 5:13–21CrossRefPubMed
15.
Zurück zum Zitat Rieber A, Zeitler H, Rosenthal H et al (1997) MRI of breast cancer: influence of chemotherapy on sensitivity. Br J Radiol 70:452–458PubMed Rieber A, Zeitler H, Rosenthal H et al (1997) MRI of breast cancer: influence of chemotherapy on sensitivity. Br J Radiol 70:452–458PubMed
16.
Zurück zum Zitat Craciunescu OI, Blackwell KL, Jones EL et al (2009) DCE-MRI parameters have potential to predict response of locally advanced breast cancer patients to neoadjuvant chemotherapy and hyperthermia: a pilot study. Int J Hyperthermia 25:405–415CrossRefPubMed Craciunescu OI, Blackwell KL, Jones EL et al (2009) DCE-MRI parameters have potential to predict response of locally advanced breast cancer patients to neoadjuvant chemotherapy and hyperthermia: a pilot study. Int J Hyperthermia 25:405–415CrossRefPubMed
17.
Zurück zum Zitat Semple SI, Staff RT, Heys SD et al (2006) Baseline MRI delivery characteristics predict change in invasive ductal breast carcinoma PET metabolism as a result of primary chemotherapy administration. Ann Oncol 17:1393–1398CrossRefPubMed Semple SI, Staff RT, Heys SD et al (2006) Baseline MRI delivery characteristics predict change in invasive ductal breast carcinoma PET metabolism as a result of primary chemotherapy administration. Ann Oncol 17:1393–1398CrossRefPubMed
18.
Zurück zum Zitat Fisher ER, Anderson S, Redmond C, Fisher B (1993) Pathologic findings from the National Surgical Adjuvant Breast Project B-06. 10-year pathologic and clinical prognostic discriminants. Cancer 71:2507–2514CrossRefPubMed Fisher ER, Anderson S, Redmond C, Fisher B (1993) Pathologic findings from the National Surgical Adjuvant Breast Project B-06. 10-year pathologic and clinical prognostic discriminants. Cancer 71:2507–2514CrossRefPubMed
19.
Zurück zum Zitat Jimenez RE, Wallis T, Visscher DW (2001) Centrally necrotizing carcinoma of the breast: a distinct histologic subtype with aggressive clinical behavior. Am J Surg Pathol 25:331–337CrossRefPubMed Jimenez RE, Wallis T, Visscher DW (2001) Centrally necrotizing carcinoma of the breast: a distinct histologic subtype with aggressive clinical behavior. Am J Surg Pathol 25:331–337CrossRefPubMed
20.
Zurück zum Zitat Leek RD, Landers RJ, Harris AL, Lewis CE (1999) Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br J Cancer 79:991–995CrossRefPubMed Leek RD, Landers RJ, Harris AL, Lewis CE (1999) Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br J Cancer 79:991–995CrossRefPubMed
21.
Zurück zum Zitat Metz S, Daldrup-Link HE, Richter T et al (2003) Detection and quantification of breast tumor necrosis with MR imaging: value of the necrosis-avid contrast agent gadophrin-3. Acad Radiol 10:484–490CrossRefPubMed Metz S, Daldrup-Link HE, Richter T et al (2003) Detection and quantification of breast tumor necrosis with MR imaging: value of the necrosis-avid contrast agent gadophrin-3. Acad Radiol 10:484–490CrossRefPubMed
22.
Zurück zum Zitat Uematsu T, Kasami M, Yuen S (2009) Triple-negative breast cancer: correlation between MR imaging and pathologic findings. Radiology 250:638–647CrossRefPubMed Uematsu T, Kasami M, Yuen S (2009) Triple-negative breast cancer: correlation between MR imaging and pathologic findings. Radiology 250:638–647CrossRefPubMed
23.
Zurück zum Zitat Tamura N, Hasebe T, Okada N et al (2009) Tumor histology in lymph vessels and lymph nodes for the accurate prediction of outcome among breast cancer patients treated with neoadjuvant chemotherapy. Cancer Sci 100:1823–1833CrossRefPubMed Tamura N, Hasebe T, Okada N et al (2009) Tumor histology in lymph vessels and lymph nodes for the accurate prediction of outcome among breast cancer patients treated with neoadjuvant chemotherapy. Cancer Sci 100:1823–1833CrossRefPubMed
24.
Zurück zum Zitat Tubiana-Hulin M, Stevens D, Lasry S et al (2006) Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution. Ann Oncol 17:1228–1233CrossRefPubMed Tubiana-Hulin M, Stevens D, Lasry S et al (2006) Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution. Ann Oncol 17:1228–1233CrossRefPubMed
25.
Zurück zum Zitat Cristofanilli M, Gonzalez-Angulo A, Sneige N et al (2005) Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes. J Clin Oncol 23:41–48CrossRefPubMed Cristofanilli M, Gonzalez-Angulo A, Sneige N et al (2005) Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes. J Clin Oncol 23:41–48CrossRefPubMed
26.
Zurück zum Zitat Chen JH, Feig B, Agrawal G et al (2008) MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy. Cancer 112:17–26CrossRefPubMed Chen JH, Feig B, Agrawal G et al (2008) MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy. Cancer 112:17–26CrossRefPubMed
Metadaten
Titel
Neoadjuvant chemotherapy for breast cancer: correlation between the baseline MR imaging findings and responses to therapy
verfasst von
Takayoshi Uematsu
Masako Kasami
Sachiko Yuen
Publikationsdatum
01.10.2010
Verlag
Springer-Verlag
Erschienen in
European Radiology / Ausgabe 10/2010
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-010-1813-8

Weitere Artikel der Ausgabe 10/2010

European Radiology 10/2010 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.